AZERIA THERAPEUTICS LIMITED - Profile & Financials

Accounts Submitted

Confirmation Statement Submitted

Net assets N/A

Total assets N/A

Total Liabilities N/A

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

4th Floor Cumberland House 15-17 Cumberland Place Southampton SO15 2BG

Credit Report

Discover AZERIA THERAPEUTICS LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

No accounts filed yet

Financial History

Revenue, profit, EBITDA and key financial figures

No Financial Data Available

Financial information will appear here once available.

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share allotments and capital structure

8 Allotments 4,476,500 Shares £3.50m Total

Date From	Share Class	Shares Allotted	Amount Raised	Price/Share
25 Oct 2019	ORDINARY	20,000	£0.2	£0
18 Jun 2019	ORDINARY	148,000	£1.48	£0
18 Jun 2019	ORDINARY	14,000	£0.14	£0
18 Jun 2019	SERIES A	1,500,000	£1.50m	£1
18 Jun 2019	ORDINARY	26,000	£0.26	£0

Officers

5 active 4 resigned

Show resigned officers

						Status
Jason Scott Carroll	Director	Australian	England	52	8 Mar 2017	Active
Magdalena Anna Jonikas	Director	British	United Kingdom	41	8 Nov 2019	Active
Martin Patrick Murphy	Director	British	United Kingdom	57	8 Nov 2019	Active
Robert Ian James	Director	British	England	61	28 Feb 2018	Active
Stephen Samuel Myatt	Director	British	United Kingdom	45	30 Mar 2017	Active

Shareholders

Shareholders (14)


Syncona Portfolio Limited	34.3%	3,805,128	Series B	19 Mar 2020
Stephen Myatt	1.3%	148,000	Ordinary	19 Mar 2020
Simon Johnston	0.2%	22,500	Ordinary	19 Mar 2020

Persons with Significant Control

Persons with Significant Control (2)

2 Active 1 Ceased

Syncona Portfolio Limited

British Channel Islands

Active

Notified 8 Nov 2019

Nature of Control

Ownership Of Shares 25 To 50 Percent
Voting Rights 25 To 50 Percent

Crt Pioneer Gp Limited

United Kingdom

Active

Notified 8 Nov 2019

Nature of Control

Ownership Of Shares 50 To 75 Percent
Voting Rights 50 To 75 Percent

Jason Scott Carroll

Ceased 8 Nov 2019

Ceased

See All Controllers

Group Structure

SYNCONA PORTFOLIO LIMITED british channel islands

CRT PIONEER GP LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent

SIXTH ELEMENT CAPITAL LLP united kingdom

AZERIA THERAPEUTICS LIMITED Current Company

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
11 May 2025	Gazette	Gazette Dissolved Liquidation	View(1 page)
11 Feb 2025	Insolvency	Liquidation Voluntary Members Return Of Final Meeting	View(22 pages)
11 Dec 2024	Insolvency	Liquidation Voluntary Appointment Of Liquidator	View(3 pages)
11 Dec 2024	Insolvency	Liquidation Voluntary Removal Of Liquidator By Court	View(8 pages)
10 Feb 2024	Insolvency	Liquidation Voluntary Statement Of Receipts And Payments With Brought Down Date	View(20 pages)